FDA Advisory Committee Vote: Invokana Should Be Approved

Not terribly surprising — and we still need to wait for a full commission vote, but in as few as six weeks’ time, Januvia should prepare to compete head to head with Invokana.

The FDA Advisory Panel just voted, 10-5, to recommend that FDA approve this new drug candidate for adults with Type-2 diabetes.

Beware what that portends for Januvia — and Whitehouse Station. This is now Merck’s biggest selling franchise.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s